Alpha 1-antitrypsin and acute anterior uveitis

Area of Science:

• Ophthalmology
• Immunogenetics
• Rheumatology

Background:

• Alpha 1-antitrypsin (A1AT), also known as alpha 1-protease inhibitor (PI), is a key protein in regulating inflammatory processes.
• The PI MZ phenotype is a genetic variant of A1AT that has been investigated for its potential role in various inflammatory conditions.
• Acute anterior uveitis (AAU) is an inflammatory eye disease that can sometimes be associated with systemic rheumatic diseases.

Purpose of the Study:

• To investigate the potential pathogenetic role of the alpha 1-antitrypsin/alpha 1-protease inhibitor (PI) MZ phenotype in the development of acute anterior uveitis (AAU).
• To determine if there is an association between the PI MZ type and the occurrence of AAU in a Finnish cohort.
• To explore potential differences in PI MZ frequencies between AAU patients with and without associated rheumatic diseases.

Main Methods:

• A cohort of 156 patients diagnosed with acute anterior uveitis (AAU) was recruited for the study.
• Serum samples from AAU patients and 120 healthy controls were analyzed using isoelectric focusing for PI typing.
• Statistical analysis was performed to compare the frequencies of the PI MZ phenotype between different groups.

Main Results:

• No statistically significant difference was observed in the frequencies of the PI MZ phenotype between patients with AAU (4.5%) and healthy controls (4.2%).
• Similarly, no significant difference was found when comparing AAU patients with associated rheumatic diseases (4.8%) to those without associated disease (4.3%).

Conclusions:

• The findings suggest that the PI MZ type is not closely associated with acute anterior uveitis (AAU) in the Finnish population.
• The study indicates that this specific genetic variant of alpha 1-antitrypsin/alpha 1-protease inhibitor does not appear to be a significant risk factor for AAU in this cohort.